Inhibition as a Transplant-Mediated Therapy: A New Paradigm for Treating Parkinson's?

Theofanis Karayannis; Gordon Fishell

doi:10.1016/j.stem.2010.02.003

Inhibition as a Transplant-Mediated Therapy: A New Paradigm for Treating Parkinson's?

Theofanis Karayannis, Gordon Fishell

Center for Genomics and Systems Biology

Research output: Contribution to journal › Short survey › peer-review

Abstract

In this issue of Cell Stem Cell, Martínez-Cerdeño and colleagues (2010) transplant interneuron precursors from the MGE into the striatum of a rat model of Parkinson's disease and observe a 5% increase in the endogenous GABAergic interneuron population resulting in behavioral benefits in both lesioned and wild-type animals.

Original language	English (US)
Pages (from-to)	184-185
Number of pages	2
Journal	Cell Stem Cell
Volume	6
Issue number	3
DOIs	https://doi.org/10.1016/j.stem.2010.02.003
State	Published - Mar 5 2010

ASJC Scopus subject areas

Molecular Medicine
Genetics
Cell Biology

Access to Document

10.1016/j.stem.2010.02.003

Cite this

@article{0c0632df2de547afbab25536a3530c2b,

title = "Inhibition as a Transplant-Mediated Therapy: A New Paradigm for Treating Parkinson's?",

abstract = "In this issue of Cell Stem Cell, Mart{\'i}nez-Cerde{\~n}o and colleagues (2010) transplant interneuron precursors from the MGE into the striatum of a rat model of Parkinson's disease and observe a 5% increase in the endogenous GABAergic interneuron population resulting in behavioral benefits in both lesioned and wild-type animals.",

author = "Theofanis Karayannis and Gordon Fishell",

year = "2010",

month = mar,

day = "5",

doi = "10.1016/j.stem.2010.02.003",

language = "English (US)",

volume = "6",

pages = "184--185",

journal = "Cell Stem Cell",

issn = "1934-5909",

publisher = "Cell Press",

number = "3",

}

TY - JOUR

T1 - Inhibition as a Transplant-Mediated Therapy

T2 - A New Paradigm for Treating Parkinson's?

AU - Karayannis, Theofanis

AU - Fishell, Gordon

PY - 2010/3/5

Y1 - 2010/3/5

N2 - In this issue of Cell Stem Cell, Martínez-Cerdeño and colleagues (2010) transplant interneuron precursors from the MGE into the striatum of a rat model of Parkinson's disease and observe a 5% increase in the endogenous GABAergic interneuron population resulting in behavioral benefits in both lesioned and wild-type animals.

AB - In this issue of Cell Stem Cell, Martínez-Cerdeño and colleagues (2010) transplant interneuron precursors from the MGE into the striatum of a rat model of Parkinson's disease and observe a 5% increase in the endogenous GABAergic interneuron population resulting in behavioral benefits in both lesioned and wild-type animals.

UR - http://www.scopus.com/inward/record.url?scp=77449104817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77449104817&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2010.02.003

DO - 10.1016/j.stem.2010.02.003

M3 - Short survey

C2 - 20207216

AN - SCOPUS:77449104817

SN - 1934-5909

VL - 6

SP - 184

EP - 185

JO - Cell Stem Cell

JF - Cell Stem Cell

IS - 3

ER -

Inhibition as a Transplant-Mediated Therapy: A New Paradigm for Treating Parkinson's?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this